Abstract:Transcription activator-like effectors (TALEs), first identified in Xanthomonas bacteria, are naturally occurring or artificially designed proteins that modulate gene transcription. These proteins recognize and bind DNA sequences based on a variable numbers of tandem repeats. Each repeat is comprised of a set of ∼ 34 conserved amino acids; within this conserved domain, there are usually two amino acids that distinguish one TALE from another. Interestingly, TALEs have revealed a simple cipher for the one-to-one recognition of proteins for DNA bases. Synthetic TALEs have been used to successfully target genes in a variety of species, including humans. Depending on the type of functional domain that is fused to the TALE of interest, these proteins can have diverse biological effects. For example, after binding DNA, TALEs fused to transcriptional activation domains can function as robust transcription factors (TALE-TFs), while fused to restriction endonucleases (TALENs) can cut DNA. Targeted genome editing, in theory, is capable of modifying any endogenous gene sequence of interest; this can be performed in cells or organisms, and may be applied to clinical gene-based therapies in the future. With current technologies, highly accurate, specific, and reliable gene editing cannot be achieved. Thus, recognition and binding mechanisms governing TALE biology are currently hot research areas. In this review, we summarize the major advances in TALE technology over the past several years with a focus on the interaction between TALEs and DNA, TALE design and construction, potential applications for this technology, and unique characteristics that make TALEs superior to zinc finger endonucleases.

[TALE Nuclease Engineering and Targeted Genome Modification].

TALEN Construction Via "unit Assembly" Method and Targeted Genome Modifications in Zebrafish.

[A Protocol for TALEN Construction and Gene Targeting in Zebrafish].

Various applications of TALEN- and CRISPR/Cas9-mediated homologous recombination to modify the Drosophila genome.

Transcription Activator‐like Effector Nucleases (talens): A Highly Efficient and Versatile Tool for Genome Editing

TALE: a tale of genome editing.

Molecular “Scissors” ——TALENs Mediated Site-specific Gene Modification Technology

[Applications of ZFN, TALEN and CRISPR/Cas9 Techniques in Disease Modeling and Gene Therapy].

Progress in zinc finger nuclease engineering for targeted genome modification]

A TALE nuclease architecture for efficient genome editing

TALEN-mediated precise genome modification by homologous recombination in zebrafish

EENdb: a Database and Knowledge Base of ZFNs and TALENs for Endonuclease Engineering

Talen or Cas9-Rapid, Efficient and Specific Choices for Genome Modifications

A single-chain TALEN architecture for genome engineering.

Utilization of TALEN and CRISPR/Cas9 technologies for gene targeting and modification.

Utilization of TALEN and CRISPR/Cas9 Technologies for Gene Targeting and Modification

Recent advances in targeted genome engineering in mammalian systems.

Targeted Mutagenesis in Zebrafish by TALENs.

Primer and interviews: advances in targeted gene modification. Interview by Julie C. Kiefer.

Progress of New-Generation Genome Editing Mediated by Engineered Endonucleases

Chromosomal Deletions and Inversions Mediated by TALENs and CRISPR/Cas in Zebrafish.